INS and type 2 diabetes mellitus: Clinically, it has demonstrated superior improvements in glycemia, insulin sensitivity, hepatic fat content (MASLD/MASH), and liver enzymes (ALT/AST) compared to either component alone, particularly in T2DM and fatty liver disease cohorts.